Cookies on the BTG website

We use cookies to ensure that we give you the best experience on our website.

If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the BTG website.

Find out more


Email to a friend
Email to a friend

* Required

Partnered Products

In addition to earning revenues from selling our own products, we earn royalties on products sold by our partners.

Product NamePartnerDescription
Lemtrada (alemtuzumab)
(ex US)
Genzyme Corporation/SanofiMultiple sclerosis
MRC Humanisation IP
Medical Research CouncilAntibody Humanisation technology for various indications.
Two-Part Hip Cup
All major orthopedic companies, including Zimmer Holdings Inc, Stryker Corporation, Smith & Nephew Inc and Biomet IncProsthetic hip joint replacement which allows a range of motion that helps to avoid dislocation.
Zytiga® (abiraterone acetate)
Janssen Pharmaceutical Companies of Johnson & JohnsonFor use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer. Approved in the US and EU, both for patients who have and those who have not received prior chemotherapy containing docetaxel.


Developing medicines for the future
developing medicines

At BTG we’re investing in our development programmes in the hope of offering patients new treatment options in the future.

Partnered programmes

We have a strong track record of partnering products successfully and a number of partnered programmes in late-stage development, which we believe may have significant commercial potential.